BioStem Technologies, Inc. (OTC: BSEM) reported Q2 EPS of $0.00, $0.27 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $74.5 million versus the consensus estimate of $44 million.

For earnings history and earnings-related data on BioStem Technologies, Inc. (BSEM) click here.